Feature | TCT | September 06, 2023

CRF Announces TCT 2023 Late-breaking Clinical Trials

Annual Scientific Symposium will take place October 23-26 in San Francisco 

Annual Scientific Symposium will take place October 23-26 in San Francisco

September 6, 2023 — The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trialsTCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. TCT, which will be held October 23-26, 2023 in San Francisco, California, at the Moscone Center, will be celebrating 35 years of leading the field. 

For more than three decades, TCT has ignited innovation, education, and connection in interventional cardiology, with the purpose of improving the survival and quality of life of patients suffering from heart and vascular disease. Every year, TCT features cutting-edge research in interventional cardiovascular medicine that directly impacts patient care and how physicians treat heart disease. 

In the fast-paced world of medical advancements, late-breaking trials are highly anticipated and offer clinicians the opportunity to learn about new interventions, drugs, techniques, or strategies that could potentially improve patient outcomes. The 12 studies selected for presentation at TCT examine the safety and effectiveness of minimally invasive techniques, pharmaceuticals, technologies, and devices that demonstrate potential to treat or prevent cardiovascular disease. Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Tuesday, October 24, Wednesday, October 25, and Thursday, October 26. 

PARTNER 3 Low-Risk 

Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial 

Martin B. Leon, MD 

EVOLUT Low Risk 

Four-Year Outcomes from the EVOLUT Low Risk Trial 

Michael J. Reardon, MD 


Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement — The WATCH TAVR Trial 

Samir R. Kapadia, MD 


Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation 

Vinod H. Thourani, MD 


Primary Outcomes of the Esprit BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial 

Ramon L. Varcoe, MD 


Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon with Conventional Balloon Angioplasty for In-Stent Restenosis 

Robert W. Yeh, MD 


Less Than 1-month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy after Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: The T-PASS Randomized Trial 

Myeong-Ki Hong, MD 


Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial 

Giovanni Luigi De Maria, MD 


A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients With Severe Tricuspid Regurgitation: The TRISCEND II Trial 

Susheel K. Kodali, MD 


Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results from the Randomized TRILUMINATE Pivotal Trial 

Suzanne V. Arnold, MD 


Transcatheter versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial) 

Josep Rodés-Cabau, MD 


One Year Outcomes from a Randomized Comparison of Transcatheter Edge-to-Edge Repair Systems For Degenerative MR: The CLASP IID Trial and Registry 

Robert L. Smith, MD and Firas Zahr, MD 

The Preliminary Program Guide can be found here: https://tct2023.crfconnect.com/program-guide. Media are invited to attend TCT and can apply for media credentials at: https://tct2023.crfconnect.com/press-registration

Find more TCT23 conference coverage here 

Related TCT Coverage: 

VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation 

VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial 

VIDEO: Unique Features of Coronary Artery Disease in Women 

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review 

Photo Gallery Highlighting TCT 2022 

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review 

TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award 

TCT 2022 Announces Winner of Shark Tank Innovation Award 

Educational Leaders Join Forces on Educational Opportunities 

Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF) 

Related Content

News | TCT

November 9, 2023 — Medinbox, a global provider of video integrated collaboration systems for interventional rooms and ...

Home November 09, 2023
News | TCT

October 30, 2023 — Shockwave Medical, Inc., which develops technologies for the treatment of cardiovascular disease, has ...

Home October 30, 2023
News | TCT

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...

Home October 26, 2023
News | TCT

October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in ...

Home October 25, 2023
News | TCT

October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical ...

Home October 25, 2023
News | TCT

October 25, 2023 — Medtronic plc, a global leader in healthcare technology, announced four-year results from the Evolut ...

Home October 25, 2023
News | TCT

October 25, 2023 — Information on a new double lumen catheter was presented by Nabil Dib, MD, MSc, FACC, FESC, during ...

Home October 25, 2023
News | TCT

October 25, 2023 — For its novel multi-lumen stent system for interventional adjustment of pulmonary blood flow in ...

Home October 25, 2023
Feature | TCT | By Melinda Taschetta-Millane

Innovation. Connection. Inspiration. The Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, the ...

Home October 20, 2023
News | TCT

October 19, 2023 — OpSens, a medical device cardiology-focused company, has announced that results of the “SAFE-TAVI ...

Home October 19, 2023
Subscribe Now